X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9899) 9899
Publication (859) 859
Newsletter (423) 423
Newspaper Article (81) 81
Book Review (78) 78
Magazine Article (75) 75
Book / eBook (18) 18
Conference Proceeding (5) 5
Web Resource (5) 5
Dissertation (4) 4
Government Document (4) 4
Book Chapter (3) 3
Trade Publication Article (3) 3
Data Set (2) 2
Streaming Video (2) 2
Transcript (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8411) 8411
antitubercular agents - administration & dosage (5082) 5082
male (4315) 4315
tuberculosis (4253) 4253
female (4105) 4105
antitubercular agents - therapeutic use (3870) 3870
adult (3469) 3469
index medicus (3276) 3276
tuberculosis, pulmonary - drug therapy (2717) 2717
middle aged (2542) 2542
tuberculosis - drug therapy (2173) 2173
antitubercular agents (1930) 1930
drug therapy, combination (1889) 1889
infectious diseases (1848) 1848
treatment outcome (1567) 1567
adolescent (1509) 1509
aged (1351) 1351
drug therapy (1272) 1272
isoniazid - administration & dosage (1236) 1236
mycobacterium tuberculosis - drug effects (1233) 1233
antitubercular agents - adverse effects (1174) 1174
animals (1166) 1166
respiratory system (1157) 1157
rifampin - administration & dosage (1154) 1154
pharmacology & pharmacy (1013) 1013
time factors (1009) 1009
drug administration schedule (1008) 1008
antitubercular agents - pharmacology (970) 970
child (969) 969
pulmonary tuberculosis (965) 965
microbiology (933) 933
research (917) 917
tuberculosis, multidrug-resistant - drug therapy (906) 906
mycobacterium-tuberculosis (854) 854
dosage and administration (851) 851
risk factors (810) 810
care and treatment (798) 798
isoniazid - therapeutic use (789) 789
immunology (731) 731
drug resistance (723) 723
mycobacterium tuberculosis - isolation & purification (719) 719
rifampin - therapeutic use (707) 707
rifampin (686) 686
young adult (670) 670
diagnosis (665) 665
drugs (645) 645
medicine, general & internal (640) 640
tuberculosis - prevention & control (635) 635
retrospective studies (633) 633
isoniazid (630) 630
mycobacterium tuberculosis (624) 624
child, preschool (621) 621
tuberculosis - epidemiology (617) 617
health aspects (593) 593
antitubercular agents - pharmacokinetics (581) 581
research article (573) 573
tuberculosis - diagnosis (570) 570
mice (568) 568
follow-up studies (561) 561
hiv (560) 560
microbial sensitivity tests (528) 528
medicine (527) 527
pyrazinamide - administration & dosage (523) 523
analysis (517) 517
tuberculosis, pulmonary - diagnosis (514) 514
infant (499) 499
infection (476) 476
ethambutol - administration & dosage (472) 472
sputum - microbiology (464) 464
tuberculosis, pulmonary - microbiology (463) 463
patient compliance (461) 461
therapy (442) 442
hiv infections - drug therapy (438) 438
chemotherapy (436) 436
hiv infections - complications (432) 432
pyrazinamide (419) 419
pharmacokinetics (412) 412
patients (398) 398
rifampicin (398) 398
antibiotics, antitubercular - administration & dosage (395) 395
antibiotics, antitubercular (383) 383
drug resistance, microbial (383) 383
directly observed therapy (382) 382
tuberculosis - microbiology (372) 372
infections (371) 371
tuberculosis, multidrug-resistant - epidemiology (369) 369
public health (368) 368
drug resistance in microorganisms (365) 365
mortality (364) 364
prospective studies (363) 363
tuberculosis, pulmonary - epidemiology (354) 354
medical research (353) 353
multidrug-resistant tuberculosis (353) 353
dose-response relationship, drug (350) 350
recurrence (348) 348
prevalence (345) 345
complications and side effects (344) 344
tuberculosis - complications (344) 344
aged, 80 and over (339) 339
drug interactions (335) 335
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8206) 8206
Russian (790) 790
Japanese (347) 347
German (299) 299
French (285) 285
Spanish (142) 142
Italian (93) 93
Polish (81) 81
Chinese (63) 63
Romanian (59) 59
Dutch (23) 23
Portuguese (20) 20
Turkish (12) 12
Ukrainian (12) 12
Croatian (11) 11
Danish (11) 11
Norwegian (10) 10
Czech (9) 9
Hebrew (7) 7
Serbian (7) 7
Korean (6) 6
Swedish (6) 6
Hungarian (5) 5
Finnish (4) 4
Bulgarian (3) 3
Lithuanian (3) 3
Slovak (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2013, Volume 13, Issue 1, pp. 27 - 35
Summary Background Intensified antibiotic treatment might improve the outcome of tuberculous meningitis. We assessed pharmacokinetics, safety, and survival... 
Infectious Disease | MYCOBACTERIUM-TUBERCULOSIS | ETHAMBUTOL | INFECTIOUS DISEASES | IN-VITRO | PHARMACOKINETICS | LEVOFLOXACIN | PULMONARY TUBERCULOSIS | INFECTION | DRUG-RESISTANCE | CEREBROSPINAL-FLUID | CIPROFLOXACIN | Fluoroquinolones | Aza Compounds - pharmacokinetics | Antitubercular Agents - adverse effects | Rifampin - pharmacokinetics | Antibiotics, Antitubercular - adverse effects | Follow-Up Studies | Humans | Middle Aged | Aza Compounds - adverse effects | Male | Quinolines - administration & dosage | Quinolines - pharmacokinetics | Young Adult | Drug Therapy, Combination - adverse effects | Rifampin - adverse effects | Adult | Female | Rifampin - administration & dosage | Antibiotics, Antitubercular - administration & dosage | Aza Compounds - administration & dosage | Anti-Infective Agents - adverse effects | Antibiotics, Antitubercular - pharmacokinetics | Tuberculosis, Meningeal - drug therapy | Drug Administration Schedule | Drug Therapy, Combination - methods | Anti-Infective Agents - administration & dosage | Antitubercular Agents - pharmacokinetics | Anti-Infective Agents - pharmacokinetics | Adolescent | Antitubercular Agents - administration & dosage | Tuberculosis, Meningeal - metabolism | Quinolines - adverse effects | Indonesia | Tuberculosis | Meningitis | Dosage and administration | Product development | Moxifloxacin | Universities and colleges | Rifampin | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2011, Volume 365, Issue 16, pp. 1471 - 1481
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2011, Volume 52, Issue 11, pp. 1374 - 1383
Background. The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)—associated tuberculous meningitis is unknown.... 
Statistical median | HIV/AIDS | Antiretrovirals | Art therapy | Meningeal tuberculosis | HIV | Mortality | Random allocation | AIDS | Arts | HIV 1 | MORTALITY | SURVIVAL | THAILAND | INFECTIOUS DISEASES | HIV-INFECTION | ERA | ADOLESCENTS | CLINICAL-TRIALS | ADULTS | RISK | MICROBIOLOGY | IMMUNOLOGY | Lamivudine - administration & dosage | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | Zidovudine - administration & dosage | Anti-HIV Agents - administration & dosage | Time Factors | Adult | Anti-Inflammatory Agents - administration & dosage | Female | HIV Infections - mortality | Antiretroviral Therapy, Highly Active - methods | Tuberculosis, Meningeal - mortality | Placebos - administration & dosage | Dexamethasone - administration & dosage | Tuberculosis, Meningeal - drug therapy | Benzoxazines - administration & dosage | Double-Blind Method | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Anti-HIV Agents - adverse effects | Treatment Outcome | Tuberculosis, Meningeal - complications | HIV Infections - complications | Antitubercular Agents - administration & dosage | HIV Infections - drug therapy | Antiviral agents | Care and treatment | Patient outcomes | Dosage and administration | Drug therapy | Health aspects | HIV infection | Comorbid patients | Tuberculous meningitis
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2015, Volume 191, Issue 1, pp. 96 - 103
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2011, Volume 365, Issue 16, pp. 1492 - 1501
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2011, Volume 365, Issue 23, pp. 2155 - 2166
Journal Article
Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | RHEUMATOID-ARTHRITIS | AUTOANTIBODIES | NECROSIS-FACTOR-ALPHA | INDUCTION | DERMATOLOGY | Anti-TNF alpha-induced lupus | THERAPY | AUTOIMMUNITY | INFLIXIMAB | ETANERCEPT | ANTI-TNF-ALPHA | EPIDEMIOLOGY | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2010, Volume 362, Issue 8, pp. 697 - 706
Journal Article